Nuclear factor erythroid 2-related factor 2 induction abrogates mitochondrial stress through parkin regulation

Narukkottil Safreena1, Jimna Mohamed Ameer2, Indu C Nair3

  • 1Cell Biology Laboratory, Centre for Development and Aging Research, Inter University Centre for Biomedical Research & Super Speciality Hospital, Mahatma Gandhi University Campus at Thalappady, Rubber Board PO, Kottayam, 686009, Kerala, India; School of Health Sciences, Purdue University, West Lafayette, IN, 47907, USA.

PubMed

Insights

Mitochondrial stress causes Parkinson

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Mitochondrial stress (MS) is a key feature of aging-associated neurodegenerative diseases like Parkinson's disease (PD).
  • Chronic MS disrupts neuronal proteostasis and leads to dopaminergic neurodegeneration.
  • The precise mechanism by which MS inactivates the E3 ubiquitin ligase parkin remains unclear.

Purpose of the Study:

  • To elucidate the mechanistic framework linking progressive changes in mitochondrial mass to MS-induced alterations in parkin activity.
  • To investigate the role of the parkin-PARIS-PGC1α pathway in response to acute and chronic mitochondrial stress.
  • To evaluate the therapeutic potential of methylene blue (MB) in mitigating mitochondrial and proteostatic failure in PD.

Main Methods:

  • Investigated the differential modulation of parkin activity by acute and chronic MS.
  • Analyzed the transcriptional control of peroxisome proliferator-activated receptor γ coactivator 1α (PGC1α) via the parkin substrate PARIS.
  • Assessed the effects of methylene blue (MB) on the NRF2-parkin axis and mitochondrial function in cells exposed to the PD neurotoxin MPP+.

Main Results:

  • Acute MS activates the parkin-PARIS-PGC1α pathway, transiently boosting mitochondrial biogenesis.
  • Chronic MS leads to parkin inactivation, PARIS accumulation, PGC1α repression, and loss of mitochondrial mass.
  • MB treatment restores parkin activity, reduces PARIS levels, reactivates PGC1α, and rejuvenates mitochondria by targeting the NRF2-parkin axis.

Conclusions:

  • Chronic mitochondrial damage significantly impairs parkin function in Parkinson's disease.
  • The NRF2-parkin axis is a critical target for therapeutic intervention in PD.
  • Methylene blue shows promise in protecting against mitochondrial and proteostatic failure in PD.

Related Concept Videos

Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
13.6K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.4K
Mitochondrial Protein Sorting01:39

Mitochondrial Protein Sorting

Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death.  Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
5.9K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.7K